HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2003-10-3366PMID 14670915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis

  2004cited by this paper
• Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice.

  2004cited by this paper
• Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis

  2003cited by this paper
• Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis

  2003cited by this paper
• Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis

  2003cited by this paper
• Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.

  2003cited by this paper
• Heterozygous recipient and donor HFE mutations associated with a hereditary haemochromatosis phenotype after liver transplantation

  2003cited by this paper
• Phenotypic expression of the C282Y/Q283P compound heterozygosity in HFE and molecular modeling of the Q283P mutation effect.

  2003cited by this paper
• Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians

  2003cited by this paper
• Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.

  2003cited by this paper
• The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis.

  2003cited by this paper
• Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation.

  2003cited by this paper
• Genetics of haemochromatosis.

  2002cited by this paper
• Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

  2002cited by this paper
• Seeking candidate mutations that affect iron homeostasis.

  2002cited by this paper
• Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse

  2002cited by this paper
• A homozygous HFE gene splice site mutation (IVS5+1 G/A) in a hereditary hemochromatosis patient of Vietnamese origin.

  2002cited by this paper
• Absence of hepcidin gene mutations in 10 Italian patients with primary iron overload.

  2002cited by this paper
• A previously undescribed nonsense mutation of the HFE gene

  2002cited by this paper
• Inactivation of the hemochromatosis gene differentially regulates duodenal expression of iron-related mRNAs between mouse strains.

  2002cited by this paper
• The Solution Structure of Human Hepcidin, a Peptide Hormone with Antimicrobial Activity That Is Involved in Iron Uptake and Hereditary Hemochromatosis* 210

  2002cited by this paper
• The hemochromatosis protein HFE inhibits iron export from macrophages

  2002cited by this paper
• Hepcidin, a new iron regulatory peptide.

  2002cited by this paper
• Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis

  2001cited by this paper
• Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

  2001cited by this paper
• Complete scanning of the hereditary hemochromatosis gene (HFE) by use of denaturing HPLC.

  2001cited by this paper
• Idiopathic hemochromatosis with the mutation of Ala176Val heterozygous for HFE gene.

  2001cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice

  2001cited by this paper
• A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin.

  2001cited by this paper
• Geography of HFE C282Y and H63D Mutations

  2000cited by this paper
• Iron homeostasis: new tales from the crypt.

  2000cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• Two novel nonsense mutations of HFE gene in five unrelated italian patients with hemochromatosis.

  2000cited by this paper
• Uncommon Mutations and Polymorphisms in the Hemochromatosis Gene

  2000cited by this paper
• Contribution of different HFE genotypes to iron overload disease: a pooled analysis

  2000cited by this paper
• Differential HFE allele expression in hemochromatosis heterozygotes.

  2000cited by this paper
• Genes that modify the hemochromatosis phenotype in mice.

  2000cited by this paper
• Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases?

  2000cited by this paper
• A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote.

  1999cited by this paper
• Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands.

  1999cited by this paper
• Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.

  1999cited by this paper
• Biosynthesis, Distinct Post-translational Modifications, and Functional Characterization of Lymphoma Proprotein Convertase*

  1997cited by this paper
• A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

  1996cited by this paper

• A Novel Hepcidin Mutation.

  2023cites this paper
• Exploration of novel clusters and prognostic value of immune‑related signatures and identify HAMP as hub gene in colorectal cancer

  2023cites this paper
• Hereditary hemochromatosis associated with the development of liver cirrhosis

  2021cites this paper
• Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease

  2021cites this paper
• HFE Genotype, Ferritin Levels and Transferrin Saturation in Patients with Suspected Hereditary Hemochromatosis

  2021cites this paper
• Hemochromatosis

  2021cites this paper
• TACG_A_269622 353..361

  2021cites this paper
• Hepcidin Signaling in Health and Disease: Ironing Out the Details

  2021cites this paper
• Determination of mutations in iron regulating genes of beta thalassemia major patients of Khyber Pakhtunkhwa, Pakistan

  2020cites this paper
• Haemochromatosis

  2019cites this paper
• STUDY OF SR. IRON, TIBC LEVELS AND HAMP GENE MUTATIONS IN SICKLE CELL DISEASE

  2019cites this paper
• 4 – Disorders of Iron Overload

  2018cites this paper
• Genetic Infiltrative Cardiomyopathies.

  2018cites this paper
• Inherited Disorders of Iron Overload

  2018influential citation
• Haemochromatosis

  2018cites this paper
• Chapter 118 – Hemochromatosis

  2017cites this paper
• Genetik metabolischer und viraler Lebererkrankungen

  2017cites this paper
• Underestimation of hepcidin concentration by time of flight mass spectrometry and competitive ELISA in hepcidin p.Gly71Asp heterozygotes

  2016cites this paper
• Haemochromatosis.

  2016cites this paper
• Iron Deficiency, Iron Overload and Therapy

  2016cites this paper
• Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload

  2016cites this paper
• Hereditary hypotransferrinemia can lead to elevated transferrin saturation and, when associated to HFE or HAMP mutations, to iron overload.

  2015cites this paper
• Lymphocytes in hemochromatosis: a genomic and functional approach

  2015cites this paper
• HFE gene: Structure, function, mutations, and associated iron abnormalities.

  2015cites this paper
• Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.

  2015cites this paper
• Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.

  2015cites this paper
• Syndrome endocrinien de l’hémochromatose héréditaire

  2014cites this paper
• The hepcidin gene promoter nc.-1010C > T; −582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene

  2014cites this paper
• Influence of iron regulating genes mutations on iron status in Egyptian patients with sickle cell disease.

  2014cites this paper
• Non-HFE hemochromatosis: pathophysiological and diagnostic aspects.

  2014cites this paper
• The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry.

  2013cites this paper
• Genotype-Phenotype Relationship in Hereditary Haemochromatosis

  2013cites this paper
• Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease

  2013cites this paper
• Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production

  2013cites this paper
• ferroportin: structure-function study The N-terminus of hepcidin is essential for its interaction with

  2013cites this paper
• Iron Metabolism and Related Disorders

  2013cites this paper
• Epistasis in iron metabolism: complex interactions between Cp, Mon1a, and Slc40a1 loci and tissue iron in mice

  2013cites this paper
• Hemoglobin, Iron, and Bilirubin

  2012cites this paper
• 5 – Disorders of iron overload

  2012cites this paper
• Non-HFE hemochromatosis

  2012cites this paper
• Identification of a novel mutation in the HAMP gene that causes non-detectable hepcidin molecules in a Japanese male patient with juvenile hemochromatosis.

  2012cites this paper
• Genetic Testing for Disorders of Iron Homeostasis

  2012cites this paper
• The significance of genetic and molecular investigations in porphyria cutanea tarda

  2012cites this paper
• Molecular Diagnostic and Pathogenesis of Hereditary Hemochromatosis

  2012cites this paper
• CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients

  2012cites this paper
• Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.

  2011cites this paper
• Understanding the structure/activity relationships of the iron regulatory peptide hepcidin.

  2011cites this paper
• Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man

  2011cites this paper
• Natural History and Management of HFE-Hemochromatosis

  2011cites this paper
• SNP and haplotype analysis reveals new HFE variants associated with iron overload trait

  2011cites this paper
• Non-HFE Hepatic Iron Overload

  2011cites this paper
• Investigations of Potential Modifier Genes in Hereditary Haemochromatosis

  2010cites this paper
• [Hereditary iron overload].

  2010cites this paper
• Phenotypic Expression of Hereditary Hemochromatosis: What Have We Learned from the Population Studies?

  2010cites this paper
• Iron Excess and Cancer

  2010cites this paper
• Genetic study of the hepcidin gene (HAMP) promoter and functional analysis of the c.-582A > G variant

  2010cites this paper
• Gender-related variations in iron metabolism and liver diseases.

  2010cites this paper
• Saturation of the Human Phenome

  2010cites this paper
• Hemojuvelin and Hepcidin Genes Sequencing in Brazilian Patients with Primary Iron Overload

  2010cites this paper
• Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.

  2010cites this paper
• Factors influencing disease phenotype and penetrance in HFE haemochromatosis

  2010influential citation
• Regulation of hepcidin and hemojuvelin expression and their role in iron homeostasis

  2010cites this paper
• Regulation of hepcidin and iron-overload disease.

  2009cites this paper
• A novel HFE mutation (c.del478) results in nonsense-mediated decay of the mutant transcript in a hemochromatosis patient.

  2009cites this paper
• Juvenile hemochromatosis due to homozygosity for the G320V mutation in the HJV gene with fatal outcome

  2009cites this paper
• HFE-Related Hemochromatosis: The Haptoglobin 2-2 Type Has a Significant but Limited Influence on Phenotypic Expression of the Predominant p.C282Y Homozygous Genotype

  2009cites this paper
• A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis

  2009cites this paper
• Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene

  2009influential citation
• Non-classical hereditary hemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes

  2009cites this paper
• [Haemochromatoses. New understanding, new treatments].

  2009cites this paper
• Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?

  2009cites this paper
• Hepcidin, the iron watcher.

  2009cites this paper
• HFE gene mutations in patients with altered iron metabolism in Argentina.

  2009cites this paper
• UGT1A1 gene polymorphism as a potential factor inducing iron overload in the pathogenesis of type 1 hereditary hemochromatosis

  2009cites this paper
• Genetics of hereditary hemochromatosis: a clinical perspective

  2009cites this paper
• Diagnosis and treatment of HFE-haemochromatosis

  2009cites this paper
• Les hémochromatoses. Nouvelle compréhension, nouveaux traitements

  2009cites this paper
• The global burden of iron overload

  2009cites this paper
• HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high‐performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants

  2009cites this paper
• Clinical penetrance of C282Y homozygous HFE hemochromatosis

  2008cites this paper
• [Acquired and genetic factors influencing the penetrance of HFE haemochromatosis].

  2008cites this paper
• Modifying factors of the HFE hemochromatosis phenotype

  2008cites this paper
• Commentary to: "Post-translational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin," by Erika Valore and Tomas Ganz.

  2008cites this paper
• Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis.

  2008cites this paper
• Iron and the liver: update 2008.

  2008cites this paper
• Current approach to hemochromatosis.

  2008cites this paper
• The Hereditary Hemochromatosis Protein, HFE, Inhibits Iron Uptake via Down-regulation of Zip14 in HepG2 Cells*

  2008cites this paper
• Facteurs acquis et génétiques de modulation de la pénétrance de l'hémochromatose HFE.

  2008cites this paper
• Hemocromatosis. nuevos aspectos clínicos y diagnósticos

  2008cites this paper
• Ironing out haemochromatosis : a study of an Indian family

  2008cites this paper
• Changes of gene expression of iron regulatory proteins during turpentine oil-induced acute-phase response in the rat

  2007cites this paper
• Hemochromatosis: An endocrine liver disease

  2007cites this paper
• Non-HFE haemochromatosis.

  2007cites this paper
• Genetic epidemiology of primary sclerosing cholangitis.

  2007cites this paper
• Physiopathologie et génétique de l'hémochromatose HFE de type 1

  2007cites this paper
• NewHJV Mutation in a Patient with Hyperferritinemia and H63D Homozygosity for theHFE Gene

  2007cites this paper
• Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance.

  2007cites this paper
• Pesquisa de las Variantes no Usuales en los Genes HFE y HAMP en Pacientes Chilenos con Fenotipo Clínico de Hemocromatosis Hereditaria

  2007cites this paper
• Iron storage disease: facts, fiction and progress.

  2007cites this paper
• Analysis of genetic variants in the 5’ regulatory region of the ALAS1 gene in South African patients with Variegate Porphyria (VP)

  2007cites this paper